WO1998015650A3 - Hydronephrosis gene (hng) and its use - Google Patents

Hydronephrosis gene (hng) and its use Download PDF

Info

Publication number
WO1998015650A3
WO1998015650A3 PCT/EP1997/005583 EP9705583W WO9815650A3 WO 1998015650 A3 WO1998015650 A3 WO 1998015650A3 EP 9705583 W EP9705583 W EP 9705583W WO 9815650 A3 WO9815650 A3 WO 9815650A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
hng
hydronephrosis
methods
diagnostic methods
Prior art date
Application number
PCT/EP1997/005583
Other languages
French (fr)
Other versions
WO1998015650A2 (en
Inventor
De Ven Willem Jan Marie Van
Jan Pierre Ghislain Joze Fryns
Peter Martinus Anthoni Groenen
Original Assignee
Vlaams Interuniv Inst Biotech
De Ven Willem Jan Marie Van
Jan Pierre Ghislain Joze Fryns
Peter Martinus Anthoni Groenen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech, De Ven Willem Jan Marie Van, Jan Pierre Ghislain Joze Fryns, Peter Martinus Anthoni Groenen filed Critical Vlaams Interuniv Inst Biotech
Priority to AU47813/97A priority Critical patent/AU4781397A/en
Publication of WO1998015650A2 publication Critical patent/WO1998015650A2/en
Publication of WO1998015650A3 publication Critical patent/WO1998015650A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

The present invention relates to the isolated form of the hydronephrosis gene (HNG) found to be involved or implied in renal diseases and disorders. The invention further relates to diagnostic methods, including prenatal diagnostic methods, based on the information encompassed in the gene and to kits and probes for performing these methods.
PCT/EP1997/005583 1996-10-09 1997-10-09 Hydronephrosis gene (hng) and its use WO1998015650A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU47813/97A AU4781397A (en) 1996-10-09 1997-10-09 Hydronephrosis gene (hng) and its use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96202820.5 1996-10-09
EP96202820 1996-10-09

Publications (2)

Publication Number Publication Date
WO1998015650A2 WO1998015650A2 (en) 1998-04-16
WO1998015650A3 true WO1998015650A3 (en) 1998-07-09

Family

ID=8224483

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/005583 WO1998015650A2 (en) 1996-10-09 1997-10-09 Hydronephrosis gene (hng) and its use

Country Status (2)

Country Link
AU (1) AU4781397A (en)
WO (1) WO1998015650A2 (en)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AUFFRAY C ET AL: "H. sapiens partial cDNA sequence; clone c-2qd11", EMBL DATABASE ENTRY (HSC2QD111), ACCESSION NO (F08104), 21-SEP-1995, 21 September 1995 (1995-09-21), XP002063411 *
GROENEN P ET AL: "Structure, sequence, and chromosome 19 localization of Human USF2 and its rearrangement in a patient with multicystic renal dysplasia", GENOMICS, vol. 38, December 1996 (1996-12-01), pages 141 - 48, XP002063412 *
MOREMAN P ET AL: "Heriditary Renal Adysplasia", PEDIATRIC PATHOLOGY, vol. 14, no. 3, 1994, pages 405 - 10, XP002063413 *
ROBSON W ET AL: "MCDK, UPJO, and VUR: A common genetic cause", AMERICAN JOURNAL OF MEDICAL GENETICS, vol. 59, no. 3, November 1995 (1995-11-01), pages 398, XP002063414 *
VIOLETT B ET AL: "Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 3, 19 January 1996 (1996-01-19), pages 1405 - 15, XP002063410 *

Also Published As

Publication number Publication date
AU4781397A (en) 1998-05-05
WO1998015650A2 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
AU7222698A (en) Method of preparing a standard diagnostic gene transcript pattern
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
WO2003008622A3 (en) Exponential nucleic acid amplification using nicking endonucleases
IL146631A0 (en) Diagnostics and therapeutics for cardiovascular disorders
WO2003071927A3 (en) Diagnostics and therapeutics for macular degeneration-related disorders
AU7625998A (en) methods, kits and compositions for suppressing the binding of detectable probe s to non-target sequences in hybridization assays
AU2002366641A1 (en) Methods for inhibiting ocular processes
WO1999058692A3 (en) Human apoptosis associated proteins
ES2166822T3 (en) CROHN DISEASE SELECTION PROCEDURES USING TNF MICROSATELITES ALELOS.
WO2000009709A3 (en) Proteases and associated proteins
EP1163515A4 (en) Therapeutic and diagnostic tools for impaired glucose tolerance conditions
WO1999052415A3 (en) Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
WO2001072777A3 (en) Human transcription factors
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
HK1042523A1 (en) Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
WO1999061614A3 (en) Human socs proteins
WO2000020604A3 (en) Oxidoreductase molecules
WO1998015650A3 (en) Hydronephrosis gene (hng) and its use
EP1019092A4 (en) Therapeutic and diagnostic tools for impaired glucose tolerance conditions
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
WO2004046382A3 (en) Product and method
WO2000028045A3 (en) Human hydrolase proteins
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001251508A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA